The global inhalation anesthesia market is estimated to grow rapidly over the next seven years, according to a Grand View Research report.
Here are four facts:
1. The market value is expected to reach a $1.5 billion value by 2022.
2. Key factors contributing to its rapid growth include the increasing geriatric population prone to chronic diseases as well as increasing number of emergency cases and growing demand for short stay ambulatory day care surgical procedure.
3. The market comprises products such as sevoflurane, isoflurane and desflurane.
4. The Sevoflurane market segment was the largest product group in 2014, accounting for over 70 percent of the demand.